InvestorsHub Logo
Followers 40
Posts 8015
Boards Moderated 0
Alias Born 12/31/2004

Re: None

Wednesday, 12/19/2018 9:02:44 AM

Wednesday, December 19, 2018 9:02:44 AM

Post# of 116745
Glaxo-Pfizer Deal Creates Biggest Over-the-Counter Drug Supplier

( How can this possibly benefit the consumers ??? )

(Bloomberg) -- GlaxoSmithKline Plc paved the way for a split into two companies, agreeing to create a consumer-health joint venture with Pfizer Inc. to be listed on the stock market, sending the U.K. company’s shares to their biggest gains in a decade.

Glaxo will have a 68 percent controlling stake in the new entity, with combined sales of $12.7 billion and led by Brian McNamara, the CEO of the U.K. pharmaceutical giant’s consumer arm. The deal lets Pfizer exit a business after a yearlong sale process failed to find a buyer.

The noncash transaction creates the world’s biggest supplier of over-the-counter medicines with brands of painkillers such as Advil and Panadol and marks a shift from Glaxo Chief Executive Officer Emma Walmsley’s previously stated strategy of keeping the steadily performing consumer and vaccine businesses under the same roof as the more volatile pharma operations.

More...
https://finance.yahoo.com/news/glaxo-pfizer-merge-advil-panadol-074045789.html

The only place where success comes before work is in the dictionary

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.